Cargando…

Tocilizumab: Lack of efficacy following off-label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732213/ http://dx.doi.org/10.1007/s40278-022-08307-0

Ejemplares similares

Tocilizumab: Off label use and lack of efficacy: case report
Publicado: (2021)

Dexamethasone/tocilizumab: Lack of efficacy following off-label therapy: case report
Publicado: (2022)

Remdesivir/tocilizumab: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone/tocilizumab: Off-label-use and lack of efficacy: case report
Publicado: (2021)

Dexamethasone/tocilizumab/tofacitinib: Lack of efficacy following off label use: 2 case reports
Publicado: (2022)

Hydroxychloroquine/lopinavir/ritonavir/tocilizumab: Lack of efficacy following off label use: case report
Publicado: (2022)

Dexamethasone/tocilizumab: Lack of efficacy during off label use: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Off-label use and lack of efficacy: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Lack of efficacy and off label use: case report
Publicado: (2021)

Methylprednisolone/tocilizumab: Lack of efficacy in off-label use: 7 case reports
Publicado: (2021)

Methylprednisolone/tocilizumab: Various toxicities, off label use and lack of efficacy: 2 case reports
Publicado: (2022)

Enoxaparin-sodium/heparin/tocilizumab: Masking of inflammatory markers following off-label use, and lack of efficacy and: 5 case reports
Publicado: (2020)

Amiodarone/norepinephrine/tocilizumab: Inflammatory perimyocarditis, pulmonary intravascular coagulopathy following off-label use, and lack of efficacy: case report
Publicado: (2021)

Tocilizumab: Anaphylaxis following off-label use: case report
Publicado: (2021)

Tocilizumab: Neutropenia following off-label use: case report
Publicado: (2021)

Epoprostenol/hydroxychloroquine/tocilizumab: Acute large bowel perforation, off-label use and lack of efficacy: case report
Publicado: (2020)

Bortezomib/ciprofloxacin/tocilizumab: Various toxicities and lack of efficacy with an off label treatment: 2 case reports
Publicado: (2021)

Dexamethasone/metronidazole/tocilizumab: Lack of efficacy following off-label use, central nerve lesions and renal failure : 2 case reports
Publicado: (2022)

Methylprednisolone: Lack of efficacy following off-label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy following off-label use: case report
Publicado: (2022)

Eculizumab: Lack of efficacy following off-label use: case report
Publicado: (2021)

Hydroxychloroquine: Lack of efficacy following an off-label use: case report
Publicado: (2021)

Tocilizumab: Septic shock following off-label use: case report
Publicado: (2020)

Tocilizumab: Lobar pneumonia following off label use: case report
Publicado: (2020)

Tocilizumab: Bacterial superinfection following off-label use: case report
Publicado: (2020)

Tocilizumab: Anastomotic leakage following off label use: case report
Publicado: (2021)

Tocilizumab: Active tuberculosis following off label use: case report
Publicado: (2021)

Tocilizumab: Cytomegalovirus colitis following off label use: case report
Publicado: (2021)

Multiple drugs: Lack off efficacy following off-label use: 2 case reports
Publicado: (2022)

Tocilizumab: Off-label use and neutropenia: case report
Publicado: (2021)

Multiple drugs: Lack of efficacy following off-label use: case report
Publicado: (2022)

Multiple drugs: Lack of efficacy following an off label use: case report
Publicado: (2022)

Multiple drugs: Lack of efficacy following off label use: case report
Publicado: (2022)

Multiple drugs: Lack of efficacy following off-label use: case report
Publicado: (2022)

Moxifloxacin/umifenovir: Lack of efficacy following off-label use: case report
Publicado: (2021)

Multiple drugs: Off-label use followed by lack of efficacy: case report
Publicado: (2021)

Multiple drugs: Lack of efficacy following off-label use: case report
Publicado: (2021)

Various drugs: Lack of efficacy following an off-label use: case report
Publicado: (2021)

Cefuroxime/oseltamivir: Lack of efficacy following off label use: case report
Publicado: (2021)

Convalescent anti SARS-CoV-2 plasma/norepinephrine/tocilizumab: Lack of efficacy and off-label use: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_re08rl1nivr9ifpgukpobaugh4